Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2026-05-26 Sale | 2026-05-28 4:15 pm | Rapport Therapeutics Inc. | RAPP | Third Rock Ventures V L.P. Third Rock Ventures GP V LP TRV GP V LLC Third Rock Ventures VI L.P. Third Rock Ventures GP VI L.P. TRV GP VI LLC 10% Owner | 18,572 | $40.05 | $743,753 | 7,249,743 (Indirect Direct) | View |
| 2026-05-11 Sale | 2026-05-13 7:06 pm | Rapport Therapeutics Inc. | RAPP | Third Rock Ventures V L.P. Third Rock Ventures GP V LP TRV GP V LLC Third Rock Ventures VI L.P. Third Rock Ventures GP VI L.P. TRV GP VI LLC 10% Owner | 133,618 | $40.24 | $5,377,323 | 7,268,315 (Indirect Direct) | View |
| 2026-05-07 Sale | 2026-05-11 5:07 pm | Rapport Therapeutics Inc. | RAPP | Third Rock Ventures V L.P. Third Rock Ventures GP V LP TRV GP V LLC Third Rock Ventures VI L.P. Third Rock Ventures GP VI L.P. TRV GP VI LLC 10% Owner | 276,513 | $40.12 | $11,094,906 | 7,401,933 (Indirect Direct) | View |
| 2026-04-17 Sale | 2026-04-21 7:36 pm | Rapport Therapeutics Inc. | RAPP | Third Rock Ventures V L.P. Third Rock Ventures GP V LP TRV GP V LLC Third Rock Ventures VI L.P. Third Rock Ventures GP VI L.P. TRV GP VI LLC 10% Owner | 426,005 | $40.32 | $17,175,244 | 7,678,446 (Indirect Direct) | View |
| 2026-04-17 Sale | 2026-04-21 4:55 pm | Rapport Therapeutics Inc. | RAPP | Yeleswaram Krishnaswamy Chief Development Officer | 20,225 | $39.99 | $808,844 | 246,426 (Direct) | View |
| 2026-04-10 Sale | 2026-04-14 4:13 pm | Rapport Therapeutics Inc. | RAPP | Yeleswaram Krishnaswamy Chief Development Officer | 19,865 | $35.03 | $695,823 | 266,651 (Direct) | View |
| 2026-04-08 Sale | 2026-04-09 4:30 pm | Rapport Therapeutics Inc. | RAPP | Yeleswaram Krishnaswamy Chief Development Officer | 360 | $34.9 | $12,564 | 286,516 (Direct) | View |
| 2026-03-30 Sale | 2026-03-31 4:27 pm | Rapport Therapeutics Inc. | RAPP | Gault Cheryl Chief Operating Officer | 10,000 | $28.19 | $281,857 | 159,914 (Direct) | View |
| 2026-03-25 Sale | 2026-03-26 4:41 pm | Rapport Therapeutics Inc. | RAPP | Yeleswaram Krishnaswamy Chief Development Officer | 10,115 | $29.99 | $303,355 | 286,876 (Direct) | View |
| 2026-03-05 Sale | 2026-03-09 4:07 pm | Rapport Therapeutics Inc. | RAPP | Gault Cheryl Chief Operating Officer | 2,014 | $28.93 | $58,265 | 169,914 (Direct) | View |
| 2026-02-18 Sale | 2026-02-19 7:06 pm | Rapport Therapeutics Inc. | RAPP | Ceesay Abraham Chief Executive Officer | 10,916 | $29.35 | $320,373 | 658,705 (Indirect Direct) | View |
| 2026-02-17 Sale | 2026-02-19 7:05 pm | Rapport Therapeutics Inc. | RAPP | Bredt David Chief Scientific Officer | 8,500 | $29.02 | $246,655 | 481,155 (Direct) | View |
| 2026-01-20 Sale | 2026-01-22 7:00 pm | Rapport Therapeutics Inc. | RAPP | Ceesay Abraham Chief Executive Officer | 10,916 | $26.11 | $285,071 | 669,621 (Indirect Direct) | View |
| 2026-01-15 Sale | 2026-01-16 4:06 pm | Rapport Therapeutics Inc. | RAPP | Bredt David Chief Scientific Officer | 8,500 | $26.84 | $228,132 | 395,575 (Direct) | View |
| 2025-12-31 Sale | 2026-01-05 4:20 pm | Rapport Therapeutics Inc. | RAPP | Bredt David Chief Scientific Officer | 6,567 | $30.05 | $197,338 | 404,075 (Direct) | View |
| 2025-12-31 Sale | 2026-01-05 4:19 pm | Rapport Therapeutics Inc. | RAPP | Yeleswaram Krishnaswamy Chief Development Officer | 2,840 | $30.05 | $85,342 | 296,991 (Direct) | View |
| 2025-12-17 Sale | 2025-12-18 4:11 pm | Rapport Therapeutics Inc. | RAPP | Ceesay Abraham Chief Executive Officer | 10,916 | $29.64 | $323,508 | 680,537 (Indirect Direct) | View |
| 2025-12-15 Sale | 2025-12-16 5:07 pm | Rapport Therapeutics Inc. | RAPP | Bredt David Chief Scientific Officer | 8,500 | $30.02 | $255,130 | 392,642 (Direct) | View |
| 2025-11-26 Sale | 2025-12-01 4:17 pm | Rapport Therapeutics Inc. | RAPP | Gault Cheryl Chief Operating Officer | 5,000 | $30.1 | $150,487 | 277,335 (Direct) | View |
| 2025-11-17 Sale | 2025-11-18 4:27 pm | Rapport Therapeutics Inc. | RAPP | Ceesay Abraham Chief Executive Officer | 10,916 | $25.2 | $275,047 | 691,453 (Indirect Direct) | View |
| 2025-11-17 Sale | 2025-11-18 4:24 pm | Rapport Therapeutics Inc. | RAPP | Bredt David Chief Scientific Officer | 8,500 | $25.19 | $214,091 | 401,142 (Direct) | View |
| 2025-10-15 Sale | 2025-10-16 4:30 pm | Rapport Therapeutics Inc. | RAPP | Bredt David Chief Scientific Officer | 8,500 | $25.79 | $219,196 | 409,642 (Direct) | View |
| 2025-10-15 Sale | 2025-10-16 4:30 pm | Rapport Therapeutics Inc. | RAPP | Ceesay Abraham Chief Executive Officer | 10,916 | $25.81 | $281,729 | 702,369 (Indirect Direct) | View |
| 2025-09-17 Sale | 2025-09-19 4:05 pm | Rapport Therapeutics Inc. | RAPP | Ceesay Abraham Chief Executive Officer | 76,420 | $26.32 | $2,011,197 | 713,285 (Indirect Direct) | View |
| 2025-09-15 Sale | 2025-09-17 4:15 pm | Rapport Therapeutics Inc. | RAPP | Bredt David Chief Scientific Officer | 8,500 | $24.19 | $205,649 | 418,142 (Direct) | View |
| 2025-09-12 Purchase | 2025-09-15 4:05 pm | Rapport Therapeutics Inc. | RAPP | Huber Reid M Director | 20,400 | $24.48 | $499,374 | 20,400 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2026-06-10 Option Award | 2026-06-10 5:57 pm | N/A 2036-06-10 | Rapport Therapeutics Inc. | RAPP | MARAGANORE JOHN Director | 15,200 | $0 | 15,200 (Direct) | View |
| 2026-06-10 Option Award | 2026-06-10 5:52 pm | N/A 2036-06-10 | Rapport Therapeutics Inc. | RAPP | PEREZ ROBERT J Director | 15,200 | $0 | 15,200 (Direct) | View |
| 2026-06-10 Option Award | 2026-06-10 5:46 pm | N/A 2036-06-10 | Rapport Therapeutics Inc. | RAPP | PAUL STEVEN M Director | 15,200 | $0 | 15,200 (Direct) | View |
| 2026-06-10 Option Award | 2026-06-10 5:28 pm | N/A 2036-06-10 | Rapport Therapeutics Inc. | RAPP | Silva Paul M Director | 15,200 | $0 | 15,200 (Direct) | View |
| 2026-06-10 Option Award | 2026-06-10 5:26 pm | N/A 2036-06-10 | Rapport Therapeutics Inc. | RAPP | HEALY JAMES Director | 15,200 | $0 | 15,200 (Direct) | View |
| 2026-06-10 Option Award | 2026-06-10 5:25 pm | N/A 2036-06-10 | Rapport Therapeutics Inc. | RAPP | Huber Reid M Director | 15,200 | $0 | 15,200 (Direct) | View |
| 2026-06-10 Option Award | 2026-06-10 5:24 pm | N/A 2036-06-10 | Rapport Therapeutics Inc. | RAPP | Young Wendy B. Director | 15,200 | $0 | 15,200 (Direct) | View |
| 2026-06-10 Option Award | 2026-06-10 5:23 pm | N/A 2036-06-10 | Rapport Therapeutics Inc. | RAPP | Sanchez Ramiro Director | 15,200 | $0 | 15,200 (Direct) | View |
| 2026-02-19 Exercise | 2026-02-19 7:05 pm | N/A N/A | Rapport Therapeutics Inc. | RAPP | Bredt David Chief Scientific Officer | 6,000 | $1.8 | 481,155 (Direct) | View |
| 2026-02-19 Exercise | 2026-02-19 7:05 pm | N/A 2033-12-05 | Rapport Therapeutics Inc. | RAPP | Bredt David Chief Scientific Officer | 6,000 | $0 | 481,155 (Direct) | View |
| 2026-02-02 Option Award | 2026-02-04 4:15 pm | N/A 2036-02-02 | Rapport Therapeutics Inc. | RAPP | Sevigny Jeffrey Chief Medical Officer | 130,000 | $0 | 130,000 (Direct) | View |
| 2026-02-02 Option Award | 2026-02-04 4:14 pm | N/A 2036-02-02 | Rapport Therapeutics Inc. | RAPP | Ceesay Abraham Chief Executive Officer | 428,000 | $0 | 428,000 (Direct) | View |
| 2026-02-02 Option Award | 2026-02-04 4:12 pm | N/A 2036-02-02 | Rapport Therapeutics Inc. | RAPP | Ignelzi Troy A. Chief Financial Officer | 148,000 | $0 | 148,000 (Direct) | View |
| 2026-02-02 Option Award | 2026-02-04 4:11 pm | N/A 2036-02-02 | Rapport Therapeutics Inc. | RAPP | Yeleswaram Krishnaswamy Chief Development Officer | 120,000 | $0 | 120,000 (Direct) | View |
| 2026-02-02 Option Award | 2026-02-04 4:09 pm | N/A 2036-02-02 | Rapport Therapeutics Inc. | RAPP | Bredt David Chief Scientific Officer | 103,000 | $0 | 103,000 (Direct) | View |
| 2026-02-02 Option Award | 2026-02-04 4:02 pm | N/A 2036-02-02 | Rapport Therapeutics Inc. | RAPP | Gault Cheryl Chief Operating Officer | 132,000 | $0 | 132,000 (Direct) | View |
| 2025-12-31 Option Award | 2026-01-05 4:20 pm | N/A N/A | Rapport Therapeutics Inc. | RAPP | Bredt David Chief Scientific Officer | 18,000 | $0 | 404,075 (Direct) | View |
| 2025-12-31 Option Award | 2026-01-05 4:19 pm | N/A N/A | Rapport Therapeutics Inc. | RAPP | Yeleswaram Krishnaswamy Chief Development Officer | 9,000 | $0 | 296,991 (Direct) | View |
| 2025-11-26 Exercise | 2025-12-01 4:17 pm | N/A N/A | Rapport Therapeutics Inc. | RAPP | Gault Cheryl Chief Operating Officer | 5,000 | $1.8 | 277,335 (Direct) | View |
| 2025-11-26 Exercise | 2025-12-01 4:17 pm | N/A 2033-12-05 | Rapport Therapeutics Inc. | RAPP | Gault Cheryl Chief Operating Officer | 5,000 | $0 | 277,335 (Direct) | View |